BEIJING (Xinhua): Chinese authorities have approved a new Covid-19 vaccine candidate for human trials, the Institute of Microbiology under the Chinese Academy of Sciences said in a statement.
The recombinant protein vaccine was issued with a clinical research permit from the National Medical Products Administration on June 19, according to the institute, which is the vaccine's main developer.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!